{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:26:23Z","timestamp":1793233583337,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jaci.2022.11.001","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T18:11:35Z","timestamp":1672855895000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Immune dysregulation"],"prefix":"10.1016","volume":"151","author":[{"given":"Andrew","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatole","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. John","family":"Looney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.11.001_bib1","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaip.2020.10.057","article-title":"Patterns of immune dysregulation in primary immunodeficiencies: a systematic review","volume":"9","author":"Mauracher","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.001_bib3","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.11.001_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib5","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1038\/ncomms8335","article-title":"Monozygotic twins discordant for common variable immunodeficiency reveal impaired DNA demethylation during naive-to-memory B-cell transition","volume":"6","author":"Rodriguez-Cortez","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.11.001_bib6","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41467-022-29450-x","article-title":"Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses","volume":"13","author":"Rodriguez-Ubreva","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.11.001_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2021.06.008","article-title":"Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications","volume":"149","author":"Abyazi","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.857050","article-title":"Seeking relevant biomarkers in common variable immunodeficiency","volume":"13","author":"Ho","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144777","article-title":"Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency","author":"Ho","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2022.11.001_bib10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","article-title":"Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis","volume":"11","author":"Tajik","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.11.001_bib11","first-page":"864","article-title":"Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease","volume":"2","author":"Matei","year":"2021","journal-title":"Med (N Y)"},{"key":"10.1016\/j.jaci.2022.11.001_bib12","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1136\/gutjnl-2020-323367","article-title":"Zonulin measurement conundrum: add confusion to confusion does not lead to clarity","volume":"70","author":"Fasano","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2022.11.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101782","article-title":"Larazotide acetate for treatment of celiac disease: a systematic review and meta-analysis of randomized controlled trials","volume":"46","author":"Hoilat","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jaci.2022.11.001_bib14","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1073\/pnas.082114899","article-title":"T-bet regulates IgG class switching and pathogenic autoantibody production","volume":"99","author":"Peng","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.11.001_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1078\/0171-2985-00198","article-title":"Expansion of CD19hiCD21lo\/neg B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia","volume":"206","author":"Warnatz","year":"2002","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2022.11.001_bib16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","article-title":"Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity","volume":"118","author":"Rubtsov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.11.001_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-associated B cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib18","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1182\/blood-2011-01-330530","article-title":"A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice","volume":"118","author":"Hao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.11.001_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.coi.2019.01.002","article-title":"T-bet+ B cells: a common denominator in protective and autoreactive antibody responses?","volume":"57","author":"Myles","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.4049\/jimmunol.1501209","article-title":"Age-associated B cells: a T-bet\u2013dependent effector with roles in protective and pathogenic immunity","volume":"195","author":"Rubtsova","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib21","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","article-title":"Challenges and opportunities for consistent classification of human B cell and plasma cell populations","volume":"10","author":"Sanz","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/imr.13068","article-title":"Molecular mechanisms controlling age-associated B cells in autoimmunity","volume":"307","author":"Phalke","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2022.11.001_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00018-022-04433-9","article-title":"Age-associated B cells in autoimmune diseases","volume":"79","author":"Mouat","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2022.11.001_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jaci.2017.04.041","article-title":"The TH1 phenotype of follicular helper T cells indicates an IFN-gamma\u2013associated immune dysregulation in patients with CD21low common variable immunodeficiency","volume":"141","author":"Unger","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq3277","article-title":"Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells","volume":"7","author":"Yang","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh0891","article-title":"The expansion of human T-bethighCD21low B cells is T cell dependent","volume":"6","author":"Keller","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib27","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.11.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104263","article-title":"Type 1 helper T cells generate CXCL9\/10-producing T-bet+ effector B cells potentially involved in the pathogenesis of rheumatoid arthritis","volume":"360","author":"Nakayama","year":"2021","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib29","article-title":"Bronchoalveolar lavage fluid reflects a TH1-CD21low B-cell interaction in CVID-related interstitial lung disease","volume":"11","author":"Friedmann","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/rccm.201911-2151OC","article-title":"Age-associated B cells appear in patients with granulomatous lung diseases","volume":"202","author":"Phalke","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.11.001_bib31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2020.07.021","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"147","author":"Verbsky","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib32","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21\u2212 human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.11.001_bib33","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20042321","article-title":"Impaired early B\u00a0cell\u00a0tolerance in patients with rheumatoid arthritis","volume":"201","author":"Samuels","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.001_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150985","article-title":"Positive and negative selection shape the human naive B cell repertoire","author":"Chen","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.11.001_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.679909","article-title":"Follicular regulatory cells: choreographers of productive germinal center responses","volume":"12","author":"Lu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib36","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41590-019-0472-4","article-title":"Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses","volume":"20","author":"Clement","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.20170901","article-title":"Deficiency in T follicular regulatory cells promotes autoimmunity","volume":"215","author":"Fu","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.001_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan4767","article-title":"Interleukin-10 from CD4+ follicular regulatory T cells promotes the germinal center response","volume":"2","author":"Laidlaw","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib39","article-title":"CD4+ follicular regulatory T cells optimize the influenza virus\u2013specific B cell response","author":"Lu","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.001_bib40","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.cell.2021.02.027","article-title":"Follicular regulatory T cells produce neuritin to regulate B cells","volume":"184","author":"Gonzalez-Figueroa","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.11.001_bib41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell\u2013derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.11.001_bib42","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"issue":"6578","key":"10.1016\/j.jaci.2022.11.001_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"6578","key":"10.1016\/j.jaci.2022.11.001_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1126\/science.abm7930","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"375","author":"Robinson","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.11.001_bib45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-022-01100-0","article-title":"Epstein-Barr virus infection: the leading cause of multiple sclerosis","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2022.11.001_bib46","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.11.001_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.830993","article-title":"A high prevalence of anti-EBNA1 heteroantibodies in systemic lupus erythematosus (SLE) supports anti-EBNA1 as an origin for SLE autoantibodies","volume":"13","author":"Laurynenka","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102332","article-title":"Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model","volume":"106","author":"Jog","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2022.11.001_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molimm.2021.01.013","article-title":"Antibodies to an Epstein Barr virus protein that cross-react with dsDNA have pathogenic potential","volume":"132","author":"Singh","year":"2021","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67024","article-title":"Latent gammaherpesvirus exacerbates arthritis through modification of age-associated B cells","volume":"10","author":"Mouat","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jaci.2022.11.001_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010297","article-title":"Age-associated B cells in viral infection","volume":"18","author":"Mouat","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaci.2022.11.001_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-gamma and interferon-gamma\u2013induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2022.11.001_bib53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2020-217470","article-title":"Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-gamma hyper-responsiveness and risk for macrophage activation syndrome","volume":"80","author":"Schulert","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2022.11.001_bib54","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/rheumatology\/keab673","article-title":"Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)","volume":"61","author":"Verweyen","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2022.11.001_bib55","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41467-020-19412-6","article-title":"Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis","volume":"11","author":"Moreira-Teixeira","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.11.001_bib56","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3389\/fimmu.2017.01633","article-title":"Type I interferons in the pathogenesis of tuberculosis: molecular drivers and immunological consequences","volume":"8","author":"Donovan","year":"2017","journal-title":"Front Immunol"},{"issue":"7507","key":"10.1016\/j.jaci.2022.11.001_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk","volume":"511","author":"Mayer-Barber","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2022.11.001_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/cmi.2016.25","article-title":"Clash of the cytokine titans: counter-regulation of interleukin-1 and type I interferon\u2013mediated inflammatory responses","volume":"14","author":"Mayer-Barber","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib59","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2022.11.001_bib60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.201903-0659OC","article-title":"Synergistic signaling of TLR and IFNalpha\/beta facilitates escape of IL-18 expression from endotoxin tolerance","volume":"201","author":"Verweyen","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.11.001_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/RHU.0b013e318205092d","article-title":"Rapid and sustained remission of systemic juvenile idiopathic arthritis\u2013associated macrophage activation syndrome through treatment with anakinra and corticosteroids","volume":"17","author":"Bruck","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib62","article-title":"Case report: life-threatening macrophage activation syndrome with fulminant myocarditis successfully rescued by high dose intravenous anakinra","volume":"8","author":"Meneghel","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2022.11.001_bib63","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s10067-018-4095-1","article-title":"Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature","volume":"37","author":"S\u00f6nmez","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib64","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147593","article-title":"IFN-gamma is essential for alveolar macrophage-driven pulmonary inflammation in macrophage activation syndrome","author":"Gao","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2022.11.001_bib65","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.42099","article-title":"Identification of distinct inflammatory programs and biomarkers in systemic juvenile idiopathic arthritis and related lung disease by serum proteome analysis","volume":"74","author":"Chen","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13075-020-02245-5","article-title":"Parenchymal lung disease in adult onset Still\u2019s disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients","volume":"22","author":"Ruscitti","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2022.11.001_bib67","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/annrheumdis-2019-216040","article-title":"Emergent high fatality lung disease in systemic juvenile arthritis","volume":"78","author":"Saper","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2022.11.001_bib68","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/art.41073","article-title":"Systemic juvenile idiopathic arthritis\u2013associated lung disease: characterization and risk factors","volume":"71","author":"Schulert","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib69","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2021-220578","article-title":"Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1\u221715 alleles","volume":"81","author":"Saper","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2022.11.001_bib70","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jaci.2007.04.037","article-title":"HLA-DRB1\u00a0alleles control allergic bronchopulmonary Aspergillosis-like pulmonary responses in humanized transgenic mice","volume":"120","author":"Koehm","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib71","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.11.001_bib72","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.42137","article-title":"The conundrum of lung disease and drug hypersensitivity-like reactions in systemic juvenile idiopathic arthritis","volume":"74","author":"Binstadt","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib73","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021013549","article-title":"Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH","author":"De Matteis","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.11.001_bib74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/art.41976","article-title":"Excess serum interleukin-18 distinguishes patients with pathogenic mutations in PSTPIP1","volume":"74","author":"Stone","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13223-022-00658-2","article-title":"Prolidase deficiency, a rare inborn error of immunity, clinical phenotypes, immunological features, and proposed treatments in twins","volume":"18","author":"Alrumayyan","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaci.2020.10.008","article-title":"COVID-19\u2013associated multisystem inflammatory syndrome in children (MIS-C): a novel disease that mimics toxic shock syndrome\u2014the superantigen hypothesis","volume":"147","author":"Noval Rivas","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib77","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1073\/pnas.2010722117","article-title":"Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation","volume":"117","author":"Cheng","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.11.001_bib78","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.str.2021.04.005","article-title":"A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in\u00a0vitro","volume":"29","author":"Cheng","year":"2021","journal-title":"Structure"},{"key":"10.1016\/j.jaci.2022.11.001_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151520","article-title":"The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children","author":"Porritt","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.11.001_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh1516","article-title":"Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children","author":"Moreews","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib81","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211381","article-title":"TIM3+ TRBV11-2 T cells and IFNgamma signature in patrolling monocytes and CD16+ NK cells delineate MIS-C","author":"Hoste","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.11.001_bib82","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41591-022-01724-3","article-title":"Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19","volume":"28","author":"Sacco","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2022.11.001_bib83","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.immuni.2021.04.003","article-title":"Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2\u2013associated multisystem inflammatory syndrome in children","volume":"54","author":"Ramaswamy","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.11.001_bib84","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15585\/mmwr.mm7102e1","article-title":"Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18\u00a0years\u2014United States, July-December 2021","volume":"71","author":"Zambrano","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2022.11.001_bib85","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149633","article-title":"Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier","author":"Yonker","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.11.001_bib86","article-title":"Zonulin antagonist, larazotide (AT1001), as an adjuvant treatment for multisystem inflammatory syndrome in children: a case series","volume":"10","author":"Yonker","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.jaci.2022.11.001_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144554","article-title":"Similarities and differences between the immunopathogenesis of COVID-19\u2013related pediatric multisystem inflammatory syndrome and Kawasaki disease","author":"Esteve-Sole","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.11.001_bib88","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1016\/S2665-9913(21)00139-9","article-title":"Inflammatory biomarkers in COVID-19\u2013associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study","volume":"3","author":"Rodriguez-Smith","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib89","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jaci.2022.02.028","article-title":"Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)","volume":"149","author":"Kumar","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib90","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147076","article-title":"Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C","author":"Zhu","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.11.001_bib91","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaci.2021.10.027","article-title":"Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies","volume":"149","author":"Lin","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib92","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/art.42139","volume":"74","author":"Romano","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib93","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/art.42087","article-title":"The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type i interferonopathies: CANDLE\/PRAAS, SAVI, and AGS","volume":"74","author":"Cetin Gedik","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib94","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.11.001_bib95","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib96","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022016642","article-title":"Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multi center study","author":"Heiblig","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.11.001_bib97","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bjh.17893","article-title":"Azacitidine for patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry","volume":"196","author":"Comont","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2022.11.001_bib98","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.41030","article-title":"Exploratory study of MYD88 L265P, rare NLRP3 variants, and clonal hematopoiesis prevalence in patients with Schnitzler syndrome","volume":"71","author":"Pathak","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib99","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jaci.2019.12.909","article-title":"Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome","volume":"145","author":"Krause","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib100","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood-2017-10-810366","article-title":"Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome","volume":"131","author":"Rowczenio","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.11.001_bib101","article-title":"Case report: therapeutic use of ibrutinib in a patient with Schnitzler syndrome","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib102","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaci.2017.01.017","article-title":"Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase","volume":"140","author":"Liu","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib103","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.11.001_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.935957","article-title":"Adenosine deaminase 2 deficiency (DADA2): a crosstalk between innate and adaptive immunity","volume":"13","author":"Signa","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/art.41549","article-title":"Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2","volume":"73","author":"Schnappauf","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.11.001_bib106","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jaci.2021.10.030","article-title":"TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2)","volume":"149","author":"Deuitch","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.11.001_bib107","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10875-021-01098-0","article-title":"Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients","volume":"41","author":"Hashem","year":"2021","journal-title":"J Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922014816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922014816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:39:13Z","timestamp":1758793153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922014816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0091674922014816"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.11.001","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune dysregulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}